(Q46990286)

27 December 2017

title

Nose-to-brain delivery of tacrine (English)

1 reference

27 December 2017

author

Ambikanandan Misra

5

1 reference

27 December 2017

author name string

Viral V Jogani

1

1 reference

27 December 2017

Pranav J Shah

2

1 reference

27 December 2017

Pushpa Mishra

3

1 reference

27 December 2017

Anil Kumar Mishra

4

1 reference

27 December 2017

publication date

1 September 2007

1 reference

27 December 2017

Journal of Pharmacy and Pharmacology

published in

1 reference

27 December 2017

volume

59

1 reference

27 December 2017

issue

9

1 reference

27 December 2017

page(s)

1199-1205

1 reference

27 December 2017

Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Nasal drug administration: potential for targeted central nervous system delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Transport of drugs from the nasal cavity to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Is nose-to-brain transport of drugs in man a reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Alzheimer's research moves to mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy: 6-(4-isothiocyanatobenzyl)-5,7-dioxo-1,11-(carboxymethyl)-1,4,8,11-tetraazacyclotridecane

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Effects of tetrahydroaminoacridine on liver function in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Tacrine for treating Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Intranasal drug delivery for brain targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Controlled release tacrine delivery system for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.9.0003

21 January 2018

Identifiers

DOI

10.1211/JPP.59.9.0003

1 reference

27 December 2017

1 reference

27 December 2017